SlideShare uma empresa Scribd logo
1 de 43
Case Studies in the Management
    of HIV-Positive Patients
     Stephen Perez, RN, NP, AAHIV-S
Overview and Objectives
• Review case studies involving the
  management of HIV-infected patient
• Apply knowledge to determine
  appropriate ARV initiation and
  management for case patients
• Engage in group discussion around the
  complexities of initiating ARV’s



                    2
Case One: Juan
• 25 y.o. Salvadorian, bisexual male.
• Tested HIV-positive 4 weeks ago after
  visiting a county clinic and being
  treated for GC/CT
• He is presenting for his first visit with you
  today
• Prior to his visit to the county clinic, he
  has not had care since 1 year ago, he
  has not had primary care since
  childhood
Case One: Juan
          • Juan brings a copy of
            his records from the
            county clinic
            – RX with Rocephin and
              Azithromycin
            – Twinrix #1
            – Positive HIV WB
            – Positive GC NAAT
              (urine), RPR non-
              reactive, neg CT NAAT
              (urine).
            – Information flyer for
              your clinic


      4
Case One: Juan
• On initial history:
   – UTI symptoms 6 weeks ago, now
     resolved
   – No other recent illnesses
   – No history of chronic illness
   – Family history relatively unknown
      • Married with one child in El Salvador
   – No Surgical Hx
   – ED visit 1 year ago for
     CAP, resolved with abx, prior ED
     visit 3 years ago, for laceration
     at work
   – NKDA, no current meds 5
Case One: Juan

• What else do we want
  to know about Juan?




            6
Case One: Juan
• What other information do we want to know about Juan?
• Previous testing
   – No previous HIV tests or STD history, no hx of ARV’s
• ETOH, Illicit Drugs
   – Drinks alcohol 3-4 times a week, intoxicated 2 times a
     week (approx. 8 beers)
• Sexual Activity
   – Sexually active with 2 male partners last sexual activity last
     week. Oral sex (no condoms), receptive anal sex (with
     condoms)
• Work History
   – Works as a cook at a local 24 hour restaurant. He works
     alternate day and night shifts
• Immunizations
   – Unknown, received a “shot” at the ED 3 years ago after
     sutures
• Mental Health History
                                  7
   – None reported
Case One: Juan
• Physical Exam
  – WNWD, NAD, BMI 26, VS wnl
  – Mild palpable LN in anterior cervical chain
  – 4cm well healed scar on left palm
  – Otherwise unremarkable




                        8
Case One: Juan
• What Lab Tests Do We Want to Order?
  –   CD4 count
  –   Viral Load
  –   CMP/CBC
  –   Hepatitis Serologies (HAV, HBV, HCV)
  –   Urinalysis
  –   Genotype
  –   Fasting Plasma Glucose, Fasting Lipids
  –   Repeat Urine GC/CT, Throat GC/CT
  –   PPD
  –   Anti-Toxoplasma IgG
                           9
Case One: Juan
• Results
  – CBC/CMP within normal
  – CD4 644, VL is 56,346
  – HBsAg neg, anti HBc Ab positive, anti HBs Ab
    positive, Total anti-HAV Ab postive, anti HCV
    Ab neg.
  – UA wnl
  – Genotype is pan-sensitive
  – Lipids: TC-1, LDL-130, HDL-50, TG-200.
  – FPG: 98
  – Repeat GC/CT negative
  – PPD 0mm, anti-toxo is <6.5
                         10
Case One: Juan
Should Juan Start Antiretroviral Therapy
(Audience Response)?
1. Yes
2. No
3. Maybe So




                     11
Case One: Juan

    • What ARV’s Would You
      Recommend for Juan?
      – ARV Naïve
      – Genotype is pan-sensitive
      – Works odd hours




       12
Case One: Juan
    What ARV’s Would You
    Recommend for Juan?
    (Audience Response)
      1. Atripla (EFV/TDF/FTC)
      2. Prezista, Norvir and
           Truvada (DAR/r +
           TDF/FTC)
      3. Reyataz, Norvir and
           Truvada (ATV/r
           +TDF/FTC)
      4. Isentress and Truvada
           (RAL + TDF/FTC)
      5. Complera
        13
           (RPV/FTC/TDF)
Case One: Juan

• What are benefits
  and risks of your
  selected ARV
  regimen?
• If starting Juan at his
  next visit, when do
  you want him to
  return for follow-up?
• How would you
  monitor his response
  to therapy?
                            14
QUESTIONS?
Case Two: Janice
• 34 year-old A.A. female with HIV
  infection
• She was diagnosed 4 years ago when
  she presented to an OB clinic at 26
  weeks, but has not been engaged in
  care since her delivery.
• She recently moved to the area, and is
  concerned because she has been
  feeling tired. Also has some intermittent
  throat pain
                     16
Case Two: Janice
            • She does not have
              her previous records
              with her but tells you
              the following
               – She took HIV meds
                 during pregnancy but
                 can’t remember the
                 names
               – Remembers “a lot of
                 pills” (yellow and white
                 )
               – Her daughter is HIV
                 negative
               – She stopped her meds
                 after delivering
       17
Case Two: Janice
• On initial history:
   – Has been feeling tired for about 3
     months
   – Intermittent night
     sweats, intermittent pain with
     swallowing ROS otherwise negative
   – Family history
      • Mother A&W with HTN, DM2, Father
        Deceased from MI
      • One daughter, 3 yrs old
   – Surgical Hx includes C-Section 3 yrs
     ago
   – ED visit 6 months ago for GI
     symptoms
   – Allergic to Sulfa
   – GYN: G2 P1, SAB X1, irregular
     menses, LMP 2 months ago
                                 18
Case Two: Janice
• What other information do we want to know about Janice?
• HIV History
   – Viral Load was undetectable while on meds, thinks her
     CD4 count was around 200, had a lot of GI side effects
     with the meds, but never missed any doses.
• ETOH, Illicit Drugs
   – Denies any alcohol or drug use. Does not smoke
• Sexual Activity
   – Has a monogamous male partner, who is HIV negative.
     They use condoms 100% of the time.
• Work History
   – Full time work at small PR firm, does not have insurance
     because she doesn’t want anyone at work to know about
     her HIV.
• Immunizations
   – Unknown, had a PPD from OB which was negative
• Mental Health History
   – Was treated for depression 5 years ago after her father passed
     away (x 1 year)               19
Case Two: Janice
• Physical Exam
  – WNWD, NAD, BMI 24, VS: BP 144/90
    otherwise wnl
  – Well healed surgical scar from C-section
  – White coating noted on posterior
    oropharynx, scrapable with tongue
    depressor
  – Otherwise unremarkable



                       20
Case Two: Janice
• What Lab Tests Do We Want to Order?
  –   CD4 count
  –   Viral Load
  –   CMP/CBC
  –   Hepatitis Serologies (HAV, HBV, HCV)
  –   Urinalysis
  –   Genotype
  –   Fasting Plasma Glucose, Fasting Lipids
  –   RPR, GC/CT
  –   PPD
  –   Pregnancy Test
  –   Anti-Toxoplasma IgG
                           21
Case Two: Janice
• Results
  – CBC Hgb: 8.7, Hct: 30, Plt 75,000, CMP: WNL
  – CD4 75, VL is 132,675
  – HBV sAg neg, anti HBc Ab negative, anti HBVs
    Ab positive, HAV total Ab postive, anti HCV Ab
    neg.
  – Genotype is pan-sensitive
  – Lipids: TC-175, LDL-98, HDL-40, TG-130. FPG: 98
  – Urine Pregnancy test, negative, UA wnl
  – PPD 0mm
  – G6PD <3 U/g Hb
  – Anti-toxoplasma IgG <6.5 IU/ml
                         22
Case Two: Janice
Does Janice needs PCP prophylaxis
(Audience Response)?

1. Yes
2. No
3. Maybe So




                    23
Case Two: Janice
What is the best option for PCP Prophylaxis for Janice
(Audience Response)?

1. Dapsone 100mg 1 tablet daily

1. Bactrim DS 1 tablet daily

1. Bactrim DS 1 tablet Q MWF

1. Mepron 1500 mg PO daily

1. Crossing your fingers

                           24
Case Two: Janice
Should Janice Start Antiretroviral Therapy
(Audience Response)?
1. Yes
2. No
3. Maybe So




                       25
Case Two: Janice

     • What ARV’s Would You
       Recommend for Janice?
       – Her genotype is pan-
         sensitive
       – You show her a medication
         chart in your office and she
         identifies Combivir and
         Kaletra as her previous
         regimen



        26
Case Two: Janice

     What ARV’s Would You
     Recommend for Janice?
     (Audience Response)
       1. Atripla (EFV/TDF/FTC)
       2. Prezista, Norvir and
          Truvada (DAR/r +
          TDF/FTC)
       3. Reyataz, Norvir and
          Truvada (ATV/r
          +TDF/FTC)
       4. Isentress and Truvada
          (RAL + TDF/FTC)
        27
Case Two: Janice

• What are benefits and
  risks of your selected ARV
  regimen?
• If starting Janice at her
  next visit, when do you
  want her to return for
  follow-up?
• How would you monitor
  her response to therapy?

                       28
Case Two: Janice




QUESTIONS?


        29
Case Three: Donna
• 53 year-old Caucasian female with HIV
  infection
• She was diagnosed 2 years ago while
  incarcerated.
• She was recently released from prison
  and has not been treated for HIV in the
  past. She is presenting today for
  primary care/HIV Care


                     30
Case Three: Donna
• She has brought in her previous records from
  prison
  – CD4 count has been between 600 and 800 with a
    nadir of 575 cells/mm3
  – Viral Loads ~ 3,000 copies
  – HBV sAg neg, anti HBc Ab negative, anti HBVs Ab
    positive, HAV total Ab postive, anti HCV Ab neg.
  – Genotype is pan-sensitive
  – She also has hypertension and hypothyroid disease
    for which she is taking:
     • HCTZ 25 mg
     • Lisinopril 20 mg
     • Levothyroxine 100 mcg
  – She has been taking prescriptions as above

                               31
Case Three: Donna
• On initial history:
   – Has been feeling well in the past few months
   – Is concerned about finding work and getting in touch
     with family
   – Family history
      • Mother deceased from trauma, Father Deceased from
        MI, Sister alive 49 with hypothyroid disease and high
        cholesterol
      • Two adult children whom she has little contact with, Alive and
        Well as far as she knows
   – Surgical Hx unremarkable
   – NKDA
   – GYN: G2 P2, LMP 5 years ago
                                  32
Case Three: Donna
• What other information do we want to know about Donna?
• HIV History
   – Previous HIV test 10 years ago which was negative. Risk factor is
     heterosexual contact
• ETOH, Illicit Drugs
   – Drinking 3-4 beers a day, no illicit drugs. Smokes ½ pack a
     day
• Sexual Activity
   – Has a monogamous female partner, who is HIV negative.
     They use barrier protection 50% of the time
• Work History
   – Previous work in retail. Is currently applying for jobs in the
     area
• Immunizations
   – UTD, had a PPD 9 mos ago which was negative
• Mental Health History
   – Was treated for depression but has been off meds since she was
     released
                                   33
Case Three: Donna
• Physical Exam
  – WNWD, NAD, BMI 28, VS: BP 128/84
    otherwise wnl
  – Unremarkable PE




                     34
Case Three: Donna
• What Lab Tests Do We Want to Order?
  – CD4 count
  – Viral Load
  – CMP/CBC
  – Urinalysis
  – Fasting Plasma Glucose, Fasting Lipids
  – RPR, GC/CT, PAP
  – Anti-Toxoplasma IgG


                       35
Case Three: Donna
• Results
  – CBC/CMP: WNL
  – CD4: 672, CD4 %: 28
  – Viral Load: 3,234 copies
  – Lipids: TC-250, LDL-162, HDL-36, TG-224. FPG:
    110
  – UA wnl
  – PAP negative
  – GC/CT, RPR negative
  – G6PD <3 U/g Hb
  – Anti-toxoplasma IgG <6.5 IU/ml
                        36
Case Three: Donna
Should Donna Start Antiretroviral
Therapy? (Audience Response)
  1. Yes
  2. No
  3. Maybe So




                     37
Case Three: Donna

• What ARV’s Would You Recommend for
  Donna?
  – Her genotype is pan-sensitive
  – She is ARV Naïve




                           38
Case Three: Donna

What ARV’s Would You Recommend for
Donna? (Audience Response)
  1. Atripla (EFV/TDF/FTC)
  2. Prezista, Norvir and Truvada (DAR/r
     + TDF/FTC)
  3. Reyataz, Norvir and Truvada (ATV/r
     +TDF/FTC)
  4. Isentress and Truvada (RAL +
     TDF/FTC)
  5. Complera (RPV/FTC/TDF)
                   39
Case Three: Donna

• What are benefits and risks of your selected
  ARV regimen?
• If starting Donna at her next visit, when do
  you want her to return for follow-up?
• How would you monitor her response to
  therapy?




                      40
Case Three: Donna




 QUESTIONS?


        41
AETC NCHCMC Contacts
Clinical Team Contacts

Stephen Perez, RN, NP, AAHIVS, HIV Clinical Specialist
stephen@healthhiv.org


Mona Moore, PA-C, MA, AAHIVS, HIV Clinical Program Specialist
Kmona@healthhiv.org




                                     42
HealthHIV
  AETC NCHCMC
  2000 S Street NW
Washington, DC 20009
   www.NCHCMC.org
     202-232-6749

Mais conteúdo relacionado

Mais procurados

91638981 case-study-scarlet-fever-repaired
91638981 case-study-scarlet-fever-repaired91638981 case-study-scarlet-fever-repaired
91638981 case-study-scarlet-fever-repairedhomeworkping4
 
Med-Surg Case Presentation german measles
Med-Surg Case Presentation german measlesMed-Surg Case Presentation german measles
Med-Surg Case Presentation german measlesVan Macabio
 
198154885 ptb-case-study
198154885 ptb-case-study198154885 ptb-case-study
198154885 ptb-case-studyhomeworkping3
 
Tier 2 UPenn Case Log
Tier 2 UPenn Case LogTier 2 UPenn Case Log
Tier 2 UPenn Case Logabbsiegail
 
Case presentation of eclamsia on known epileptic
Case presentation of eclamsia on known epilepticCase presentation of eclamsia on known epileptic
Case presentation of eclamsia on known epilepticzerihunwelde1
 
Usmle step 2 ck 2021 updated recall collection (dr notes.com)
Usmle step 2 ck 2021 updated recall collection (dr notes.com)Usmle step 2 ck 2021 updated recall collection (dr notes.com)
Usmle step 2 ck 2021 updated recall collection (dr notes.com)usmlematerialsnet
 
83286614 case-study-ptb-class iii
83286614 case-study-ptb-class iii83286614 case-study-ptb-class iii
83286614 case-study-ptb-class iiihomeworkping3
 
Long case on hypoparathyroidism bya dr.hasan al banna
Long case on hypoparathyroidism bya dr.hasan al bannaLong case on hypoparathyroidism bya dr.hasan al banna
Long case on hypoparathyroidism bya dr.hasan al bannarummandr29
 
Case study gastro pediatric
Case study gastro pediatricCase study gastro pediatric
Case study gastro pediatricMuna Here
 
The Green Light - Medicinal Cannabis in New York (Full Version)
The Green Light - Medicinal Cannabis in New York (Full Version)The Green Light - Medicinal Cannabis in New York (Full Version)
The Green Light - Medicinal Cannabis in New York (Full Version)Dave Porter
 
Usmle step 2 ck march 2021 recalls (dr notes.com)
Usmle step 2 ck march 2021 recalls (dr notes.com)Usmle step 2 ck march 2021 recalls (dr notes.com)
Usmle step 2 ck march 2021 recalls (dr notes.com)usmlematerialsnet
 
Grand Round (Medicine Unit)
Grand Round (Medicine Unit)Grand Round (Medicine Unit)
Grand Round (Medicine Unit)Sakkar Chowdhury
 
Pediatric tuberculosis case presentation
Pediatric tuberculosis case presentationPediatric tuberculosis case presentation
Pediatric tuberculosis case presentationAhumuza Denis
 
8. Acute Lymphoblastic Leukemia
8. Acute Lymphoblastic Leukemia8. Acute Lymphoblastic Leukemia
8. Acute Lymphoblastic LeukemiaWhiteraven68
 
PRN Medications; its justified use: by Dr Prithvi Puwar
PRN Medications; its justified use: by Dr Prithvi PuwarPRN Medications; its justified use: by Dr Prithvi Puwar
PRN Medications; its justified use: by Dr Prithvi PuwarPrithvi Puwar
 
Clinico social case Presentation
Clinico social case PresentationClinico social case Presentation
Clinico social case PresentationKyaw San Lin
 

Mais procurados (20)

Ncp Osteomyelytis
Ncp OsteomyelytisNcp Osteomyelytis
Ncp Osteomyelytis
 
91638981 case-study-scarlet-fever-repaired
91638981 case-study-scarlet-fever-repaired91638981 case-study-scarlet-fever-repaired
91638981 case-study-scarlet-fever-repaired
 
Pediatrics/Case Report: Cardiomyopathy
Pediatrics/Case Report: CardiomyopathyPediatrics/Case Report: Cardiomyopathy
Pediatrics/Case Report: Cardiomyopathy
 
Med-Surg Case Presentation german measles
Med-Surg Case Presentation german measlesMed-Surg Case Presentation german measles
Med-Surg Case Presentation german measles
 
198154885 ptb-case-study
198154885 ptb-case-study198154885 ptb-case-study
198154885 ptb-case-study
 
Tier 2 UPenn Case Log
Tier 2 UPenn Case LogTier 2 UPenn Case Log
Tier 2 UPenn Case Log
 
Case presentation of eclamsia on known epileptic
Case presentation of eclamsia on known epilepticCase presentation of eclamsia on known epileptic
Case presentation of eclamsia on known epileptic
 
Usmle step 2 ck 2021 updated recall collection (dr notes.com)
Usmle step 2 ck 2021 updated recall collection (dr notes.com)Usmle step 2 ck 2021 updated recall collection (dr notes.com)
Usmle step 2 ck 2021 updated recall collection (dr notes.com)
 
83286614 case-study-ptb-class iii
83286614 case-study-ptb-class iii83286614 case-study-ptb-class iii
83286614 case-study-ptb-class iii
 
Long case on hypoparathyroidism bya dr.hasan al banna
Long case on hypoparathyroidism bya dr.hasan al bannaLong case on hypoparathyroidism bya dr.hasan al banna
Long case on hypoparathyroidism bya dr.hasan al banna
 
Case study gastro pediatric
Case study gastro pediatricCase study gastro pediatric
Case study gastro pediatric
 
The Green Light - Medicinal Cannabis in New York (Full Version)
The Green Light - Medicinal Cannabis in New York (Full Version)The Green Light - Medicinal Cannabis in New York (Full Version)
The Green Light - Medicinal Cannabis in New York (Full Version)
 
Usmle step 2 ck march 2021 recalls (dr notes.com)
Usmle step 2 ck march 2021 recalls (dr notes.com)Usmle step 2 ck march 2021 recalls (dr notes.com)
Usmle step 2 ck march 2021 recalls (dr notes.com)
 
Grand Round (Medicine Unit)
Grand Round (Medicine Unit)Grand Round (Medicine Unit)
Grand Round (Medicine Unit)
 
Pediatric tuberculosis case presentation
Pediatric tuberculosis case presentationPediatric tuberculosis case presentation
Pediatric tuberculosis case presentation
 
8. Acute Lymphoblastic Leukemia
8. Acute Lymphoblastic Leukemia8. Acute Lymphoblastic Leukemia
8. Acute Lymphoblastic Leukemia
 
PRN Medications; its justified use: by Dr Prithvi Puwar
PRN Medications; its justified use: by Dr Prithvi PuwarPRN Medications; its justified use: by Dr Prithvi Puwar
PRN Medications; its justified use: by Dr Prithvi Puwar
 
Early Infant Diagnosis of HIV-1
Early Infant Diagnosis of HIV-1Early Infant Diagnosis of HIV-1
Early Infant Diagnosis of HIV-1
 
Clinico social case Presentation
Clinico social case PresentationClinico social case Presentation
Clinico social case Presentation
 
7. iddm1
7. iddm17. iddm1
7. iddm1
 

Destaque

Treatment as prevention wong
Treatment as prevention wongTreatment as prevention wong
Treatment as prevention wonghealthhiv
 
Syn cing chronic disease advocacy boutin
Syn cing chronic disease advocacy boutinSyn cing chronic disease advocacy boutin
Syn cing chronic disease advocacy boutinhealthhiv
 
Treatment as prevention holtgrave
Treatment as prevention holtgraveTreatment as prevention holtgrave
Treatment as prevention holtgravehealthhiv
 
Syn cing chronic disease advocacy sandt
Syn cing chronic disease advocacy sandtSyn cing chronic disease advocacy sandt
Syn cing chronic disease advocacy sandthealthhiv
 
New frontiers kostman
New frontiers kostmanNew frontiers kostman
New frontiers kostmanhealthhiv
 
Minority providers jordan
Minority providers jordanMinority providers jordan
Minority providers jordanhealthhiv
 
Treatment as prevention levi
Treatment as prevention levi Treatment as prevention levi
Treatment as prevention levi healthhiv
 
SYNCing Guidelines- Catanzaro
SYNCing Guidelines- CatanzaroSYNCing Guidelines- Catanzaro
SYNCing Guidelines- Catanzarohealthhiv
 

Destaque (8)

Treatment as prevention wong
Treatment as prevention wongTreatment as prevention wong
Treatment as prevention wong
 
Syn cing chronic disease advocacy boutin
Syn cing chronic disease advocacy boutinSyn cing chronic disease advocacy boutin
Syn cing chronic disease advocacy boutin
 
Treatment as prevention holtgrave
Treatment as prevention holtgraveTreatment as prevention holtgrave
Treatment as prevention holtgrave
 
Syn cing chronic disease advocacy sandt
Syn cing chronic disease advocacy sandtSyn cing chronic disease advocacy sandt
Syn cing chronic disease advocacy sandt
 
New frontiers kostman
New frontiers kostmanNew frontiers kostman
New frontiers kostman
 
Minority providers jordan
Minority providers jordanMinority providers jordan
Minority providers jordan
 
Treatment as prevention levi
Treatment as prevention levi Treatment as prevention levi
Treatment as prevention levi
 
SYNCing Guidelines- Catanzaro
SYNCing Guidelines- CatanzaroSYNCing Guidelines- Catanzaro
SYNCing Guidelines- Catanzaro
 

Semelhante a Treatment outcome case studies perez

Getting to Zero: Implementing PrEP and PEP in School-Based Health Centers
Getting to Zero: Implementing PrEP and PEP in School-Based Health CentersGetting to Zero: Implementing PrEP and PEP in School-Based Health Centers
Getting to Zero: Implementing PrEP and PEP in School-Based Health CentersCalifornia School-Based Health Alliance
 
Hepatitis C Presentation
Hepatitis C PresentationHepatitis C Presentation
Hepatitis C PresentationJoseph Helms
 
The Green Light - Medicinal Cannabis in New York (Presentation Version)
The Green Light - Medicinal Cannabis in New York (Presentation Version)The Green Light - Medicinal Cannabis in New York (Presentation Version)
The Green Light - Medicinal Cannabis in New York (Presentation Version)Dave Porter
 
Bowie State Nursing Care Plan.pdf
Bowie State Nursing Care Plan.pdfBowie State Nursing Care Plan.pdf
Bowie State Nursing Care Plan.pdfbkbk37
 
Weitzman ECHO: COVID-19 in Primary Care
Weitzman ECHO: COVID-19 in Primary CareWeitzman ECHO: COVID-19 in Primary Care
Weitzman ECHO: COVID-19 in Primary CareCHC Connecticut
 
Cm 1. dhiman leukemia
Cm 1. dhiman leukemiaCm 1. dhiman leukemia
Cm 1. dhiman leukemiaDrDhimanBD
 
Miami Regional UniversityDate of Encounter06182020S
Miami Regional UniversityDate of Encounter06182020SMiami Regional UniversityDate of Encounter06182020S
Miami Regional UniversityDate of Encounter06182020SDioneWang844
 
soap 1.docx
soap 1.docxsoap 1.docx
soap 1.docxbkbk37
 
Yan 2Yichao YanKara WilliamsESL 10696 April 2019 Rough.docx
Yan 2Yichao YanKara WilliamsESL 10696 April 2019 Rough.docxYan 2Yichao YanKara WilliamsESL 10696 April 2019 Rough.docx
Yan 2Yichao YanKara WilliamsESL 10696 April 2019 Rough.docxadampcarr67227
 
SOAP NOTE SAMPLE FORMAT FOR MRCName  LPDateTime 1315.docx
SOAP NOTE SAMPLE FORMAT FOR MRCName  LPDateTime 1315.docxSOAP NOTE SAMPLE FORMAT FOR MRCName  LPDateTime 1315.docx
SOAP NOTE SAMPLE FORMAT FOR MRCName  LPDateTime 1315.docxrosemariebrayshaw
 
Soap Note 1 Acute Conditions.docx
Soap Note 1 Acute Conditions.docxSoap Note 1 Acute Conditions.docx
Soap Note 1 Acute Conditions.docxwrite5
 
7. When to start ART (Eligibility)Rev.pptx
7. When to start ART (Eligibility)Rev.pptx7. When to start ART (Eligibility)Rev.pptx
7. When to start ART (Eligibility)Rev.pptxyakemichael
 
STIs.pptx medicine and nursing powerpoit
STIs.pptx medicine and nursing powerpoitSTIs.pptx medicine and nursing powerpoit
STIs.pptx medicine and nursing powerpoit1901600146
 
Fever without a focus 
(Pediatric Mystery)
Fever without a focus 
(Pediatric Mystery) Fever without a focus 
(Pediatric Mystery)
Fever without a focus 
(Pediatric Mystery) deiaaldeen khudhair
 
Malaria in pregnancy case presentation edited
Malaria in pregnancy case presentation editedMalaria in pregnancy case presentation edited
Malaria in pregnancy case presentation editedVictor Effiom
 
Nursing Pharmacology Discussions.docx
Nursing Pharmacology Discussions.docxNursing Pharmacology Discussions.docx
Nursing Pharmacology Discussions.docxstirlingvwriters
 

Semelhante a Treatment outcome case studies perez (20)

OSCE REVISION .pptx
OSCE REVISION .pptxOSCE REVISION .pptx
OSCE REVISION .pptx
 
Guidances
GuidancesGuidances
Guidances
 
Getting to Zero: Implementing PrEP and PEP in School-Based Health Centers
Getting to Zero: Implementing PrEP and PEP in School-Based Health CentersGetting to Zero: Implementing PrEP and PEP in School-Based Health Centers
Getting to Zero: Implementing PrEP and PEP in School-Based Health Centers
 
Hepatitis C Presentation
Hepatitis C PresentationHepatitis C Presentation
Hepatitis C Presentation
 
The Green Light - Medicinal Cannabis in New York (Presentation Version)
The Green Light - Medicinal Cannabis in New York (Presentation Version)The Green Light - Medicinal Cannabis in New York (Presentation Version)
The Green Light - Medicinal Cannabis in New York (Presentation Version)
 
Itp.kanta
Itp.kantaItp.kanta
Itp.kanta
 
Bowie State Nursing Care Plan.pdf
Bowie State Nursing Care Plan.pdfBowie State Nursing Care Plan.pdf
Bowie State Nursing Care Plan.pdf
 
Screening and Treatment Related Issues in HIV
Screening and Treatment Related Issues in HIVScreening and Treatment Related Issues in HIV
Screening and Treatment Related Issues in HIV
 
Weitzman ECHO: COVID-19 in Primary Care
Weitzman ECHO: COVID-19 in Primary CareWeitzman ECHO: COVID-19 in Primary Care
Weitzman ECHO: COVID-19 in Primary Care
 
Cm 1. dhiman leukemia
Cm 1. dhiman leukemiaCm 1. dhiman leukemia
Cm 1. dhiman leukemia
 
Miami Regional UniversityDate of Encounter06182020S
Miami Regional UniversityDate of Encounter06182020SMiami Regional UniversityDate of Encounter06182020S
Miami Regional UniversityDate of Encounter06182020S
 
soap 1.docx
soap 1.docxsoap 1.docx
soap 1.docx
 
Yan 2Yichao YanKara WilliamsESL 10696 April 2019 Rough.docx
Yan 2Yichao YanKara WilliamsESL 10696 April 2019 Rough.docxYan 2Yichao YanKara WilliamsESL 10696 April 2019 Rough.docx
Yan 2Yichao YanKara WilliamsESL 10696 April 2019 Rough.docx
 
SOAP NOTE SAMPLE FORMAT FOR MRCName  LPDateTime 1315.docx
SOAP NOTE SAMPLE FORMAT FOR MRCName  LPDateTime 1315.docxSOAP NOTE SAMPLE FORMAT FOR MRCName  LPDateTime 1315.docx
SOAP NOTE SAMPLE FORMAT FOR MRCName  LPDateTime 1315.docx
 
Soap Note 1 Acute Conditions.docx
Soap Note 1 Acute Conditions.docxSoap Note 1 Acute Conditions.docx
Soap Note 1 Acute Conditions.docx
 
7. When to start ART (Eligibility)Rev.pptx
7. When to start ART (Eligibility)Rev.pptx7. When to start ART (Eligibility)Rev.pptx
7. When to start ART (Eligibility)Rev.pptx
 
STIs.pptx medicine and nursing powerpoit
STIs.pptx medicine and nursing powerpoitSTIs.pptx medicine and nursing powerpoit
STIs.pptx medicine and nursing powerpoit
 
Fever without a focus 
(Pediatric Mystery)
Fever without a focus 
(Pediatric Mystery) Fever without a focus 
(Pediatric Mystery)
Fever without a focus 
(Pediatric Mystery)
 
Malaria in pregnancy case presentation edited
Malaria in pregnancy case presentation editedMalaria in pregnancy case presentation edited
Malaria in pregnancy case presentation edited
 
Nursing Pharmacology Discussions.docx
Nursing Pharmacology Discussions.docxNursing Pharmacology Discussions.docx
Nursing Pharmacology Discussions.docx
 

Mais de healthhiv

Kharfen: DC HIV Public-Private Partnerships
Kharfen: DC HIV Public-Private PartnershipsKharfen: DC HIV Public-Private Partnerships
Kharfen: DC HIV Public-Private Partnershipshealthhiv
 
Pappas-National HIV / AIDS Strategy- Implications in Metro Washington, DC
Pappas-National HIV / AIDS Strategy- Implications in Metro Washington, DCPappas-National HIV / AIDS Strategy- Implications in Metro Washington, DC
Pappas-National HIV / AIDS Strategy- Implications in Metro Washington, DChealthhiv
 
The Health Center Program and the NHAS and VHAP
The Health Center Program and the NHAS and VHAPThe Health Center Program and the NHAS and VHAP
The Health Center Program and the NHAS and VHAPhealthhiv
 
Vos: Meaningful Dialogue: on Housing & Health
Vos: Meaningful Dialogue: on Housing & Health Vos: Meaningful Dialogue: on Housing & Health
Vos: Meaningful Dialogue: on Housing & Health healthhiv
 
SYNCing Government Agencies with NHAS and VHAP
SYNCing Government Agencies  with NHAS and VHAP  SYNCing Government Agencies  with NHAS and VHAP
SYNCing Government Agencies with NHAS and VHAP healthhiv
 
Sustainability & Revenue Generation for Nonprofit Organizations
Sustainability & Revenue Generation for Nonprofit OrganizationsSustainability & Revenue Generation for Nonprofit Organizations
Sustainability & Revenue Generation for Nonprofit Organizationshealthhiv
 
Syn cing chronic disease advocacy sykes
Syn cing chronic disease advocacy sykesSyn cing chronic disease advocacy sykes
Syn cing chronic disease advocacy sykeshealthhiv
 
Syn cing chronic disease advocacy greewald
Syn cing chronic disease advocacy greewaldSyn cing chronic disease advocacy greewald
Syn cing chronic disease advocacy greewaldhealthhiv
 
Syn cing chronic disease advocacy mclver
Syn cing chronic disease advocacy mclverSyn cing chronic disease advocacy mclver
Syn cing chronic disease advocacy mclverhealthhiv
 
State of the science sweeny
State of the science sweenyState of the science sweeny
State of the science sweenyhealthhiv
 
State of the science nieves rivera
State of the science nieves riveraState of the science nieves rivera
State of the science nieves riverahealthhiv
 
State of the science halkitis
State of the science halkitisState of the science halkitis
State of the science halkitishealthhiv
 
Pep and pr ep cranston
Pep and pr ep cranstonPep and pr ep cranston
Pep and pr ep cranstonhealthhiv
 
Pep and prep cahill
Pep and prep cahillPep and prep cahill
Pep and prep cahillhealthhiv
 
Pep and prep smith
Pep and prep smithPep and prep smith
Pep and prep smithhealthhiv
 
Minority providers
Minority providersMinority providers
Minority providershealthhiv
 
Building leadership pontemayor
Building leadership pontemayorBuilding leadership pontemayor
Building leadership pontemayorhealthhiv
 
Org sustainability handout2
Org sustainability handout2Org sustainability handout2
Org sustainability handout2healthhiv
 
Complying with federal grant regs
Complying with federal grant regsComplying with federal grant regs
Complying with federal grant regshealthhiv
 
Behavior based budgeting
Behavior based budgetingBehavior based budgeting
Behavior based budgetinghealthhiv
 

Mais de healthhiv (20)

Kharfen: DC HIV Public-Private Partnerships
Kharfen: DC HIV Public-Private PartnershipsKharfen: DC HIV Public-Private Partnerships
Kharfen: DC HIV Public-Private Partnerships
 
Pappas-National HIV / AIDS Strategy- Implications in Metro Washington, DC
Pappas-National HIV / AIDS Strategy- Implications in Metro Washington, DCPappas-National HIV / AIDS Strategy- Implications in Metro Washington, DC
Pappas-National HIV / AIDS Strategy- Implications in Metro Washington, DC
 
The Health Center Program and the NHAS and VHAP
The Health Center Program and the NHAS and VHAPThe Health Center Program and the NHAS and VHAP
The Health Center Program and the NHAS and VHAP
 
Vos: Meaningful Dialogue: on Housing & Health
Vos: Meaningful Dialogue: on Housing & Health Vos: Meaningful Dialogue: on Housing & Health
Vos: Meaningful Dialogue: on Housing & Health
 
SYNCing Government Agencies with NHAS and VHAP
SYNCing Government Agencies  with NHAS and VHAP  SYNCing Government Agencies  with NHAS and VHAP
SYNCing Government Agencies with NHAS and VHAP
 
Sustainability & Revenue Generation for Nonprofit Organizations
Sustainability & Revenue Generation for Nonprofit OrganizationsSustainability & Revenue Generation for Nonprofit Organizations
Sustainability & Revenue Generation for Nonprofit Organizations
 
Syn cing chronic disease advocacy sykes
Syn cing chronic disease advocacy sykesSyn cing chronic disease advocacy sykes
Syn cing chronic disease advocacy sykes
 
Syn cing chronic disease advocacy greewald
Syn cing chronic disease advocacy greewaldSyn cing chronic disease advocacy greewald
Syn cing chronic disease advocacy greewald
 
Syn cing chronic disease advocacy mclver
Syn cing chronic disease advocacy mclverSyn cing chronic disease advocacy mclver
Syn cing chronic disease advocacy mclver
 
State of the science sweeny
State of the science sweenyState of the science sweeny
State of the science sweeny
 
State of the science nieves rivera
State of the science nieves riveraState of the science nieves rivera
State of the science nieves rivera
 
State of the science halkitis
State of the science halkitisState of the science halkitis
State of the science halkitis
 
Pep and pr ep cranston
Pep and pr ep cranstonPep and pr ep cranston
Pep and pr ep cranston
 
Pep and prep cahill
Pep and prep cahillPep and prep cahill
Pep and prep cahill
 
Pep and prep smith
Pep and prep smithPep and prep smith
Pep and prep smith
 
Minority providers
Minority providersMinority providers
Minority providers
 
Building leadership pontemayor
Building leadership pontemayorBuilding leadership pontemayor
Building leadership pontemayor
 
Org sustainability handout2
Org sustainability handout2Org sustainability handout2
Org sustainability handout2
 
Complying with federal grant regs
Complying with federal grant regsComplying with federal grant regs
Complying with federal grant regs
 
Behavior based budgeting
Behavior based budgetingBehavior based budgeting
Behavior based budgeting
 

Último

Glomerular Filtration and determinants of glomerular filtration .pptx
Glomerular Filtration and  determinants of glomerular filtration .pptxGlomerular Filtration and  determinants of glomerular filtration .pptx
Glomerular Filtration and determinants of glomerular filtration .pptxDr.Nusrat Tariq
 
Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)Mohamed Rizk Khodair
 
Measurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptxMeasurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptxDr. Dheeraj Kumar
 
Book Call Girls in Yelahanka - For 7001305949 Cheap & Best with original Photos
Book Call Girls in Yelahanka - For 7001305949 Cheap & Best with original PhotosBook Call Girls in Yelahanka - For 7001305949 Cheap & Best with original Photos
Book Call Girls in Yelahanka - For 7001305949 Cheap & Best with original Photosnarwatsonia7
 
call girls in paharganj DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in paharganj DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️call girls in paharganj DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in paharganj DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️saminamagar
 
Housewife Call Girls Bangalore - Call 7001305949 Rs-3500 with A/C Room Cash o...
Housewife Call Girls Bangalore - Call 7001305949 Rs-3500 with A/C Room Cash o...Housewife Call Girls Bangalore - Call 7001305949 Rs-3500 with A/C Room Cash o...
Housewife Call Girls Bangalore - Call 7001305949 Rs-3500 with A/C Room Cash o...narwatsonia7
 
Low Rate Call Girls Mumbai Suman 9910780858 Independent Escort Service Mumbai
Low Rate Call Girls Mumbai Suman 9910780858 Independent Escort Service MumbaiLow Rate Call Girls Mumbai Suman 9910780858 Independent Escort Service Mumbai
Low Rate Call Girls Mumbai Suman 9910780858 Independent Escort Service Mumbaisonalikaur4
 
Call Girl Koramangala | 7001305949 At Low Cost Cash Payment Booking
Call Girl Koramangala | 7001305949 At Low Cost Cash Payment BookingCall Girl Koramangala | 7001305949 At Low Cost Cash Payment Booking
Call Girl Koramangala | 7001305949 At Low Cost Cash Payment Bookingnarwatsonia7
 
Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.ANJALI
 
Housewife Call Girls Hsr Layout - Call 7001305949 Rs-3500 with A/C Room Cash ...
Housewife Call Girls Hsr Layout - Call 7001305949 Rs-3500 with A/C Room Cash ...Housewife Call Girls Hsr Layout - Call 7001305949 Rs-3500 with A/C Room Cash ...
Housewife Call Girls Hsr Layout - Call 7001305949 Rs-3500 with A/C Room Cash ...narwatsonia7
 
Noida Sector 135 Call Girls ( 9873940964 ) Book Hot And Sexy Girls In A Few C...
Noida Sector 135 Call Girls ( 9873940964 ) Book Hot And Sexy Girls In A Few C...Noida Sector 135 Call Girls ( 9873940964 ) Book Hot And Sexy Girls In A Few C...
Noida Sector 135 Call Girls ( 9873940964 ) Book Hot And Sexy Girls In A Few C...rajnisinghkjn
 
epilepsy and status epilepticus for undergraduate.pptx
epilepsy and status epilepticus  for undergraduate.pptxepilepsy and status epilepticus  for undergraduate.pptx
epilepsy and status epilepticus for undergraduate.pptxMohamed Rizk Khodair
 
Call Girls Jp Nagar Just Call 7001305949 Top Class Call Girl Service Available
Call Girls Jp Nagar Just Call 7001305949 Top Class Call Girl Service AvailableCall Girls Jp Nagar Just Call 7001305949 Top Class Call Girl Service Available
Call Girls Jp Nagar Just Call 7001305949 Top Class Call Girl Service Availablenarwatsonia7
 
Case Report Peripartum Cardiomyopathy.pptx
Case Report Peripartum Cardiomyopathy.pptxCase Report Peripartum Cardiomyopathy.pptx
Case Report Peripartum Cardiomyopathy.pptxNiranjan Chavan
 
Call Girls Service Nandiambakkam | 7001305949 At Low Cost Cash Payment Booking
Call Girls Service Nandiambakkam | 7001305949 At Low Cost Cash Payment BookingCall Girls Service Nandiambakkam | 7001305949 At Low Cost Cash Payment Booking
Call Girls Service Nandiambakkam | 7001305949 At Low Cost Cash Payment BookingNehru place Escorts
 
Call Girls Service in Virugambakkam - 7001305949 | 24x7 Service Available Nea...
Call Girls Service in Virugambakkam - 7001305949 | 24x7 Service Available Nea...Call Girls Service in Virugambakkam - 7001305949 | 24x7 Service Available Nea...
Call Girls Service in Virugambakkam - 7001305949 | 24x7 Service Available Nea...Nehru place Escorts
 
Report Back from SGO: What’s New in Uterine Cancer?.pptx
Report Back from SGO: What’s New in Uterine Cancer?.pptxReport Back from SGO: What’s New in Uterine Cancer?.pptx
Report Back from SGO: What’s New in Uterine Cancer?.pptxbkling
 
Radiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxRadiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxDr. Dheeraj Kumar
 
Hematology and Immunology - Leukocytes Functions
Hematology and Immunology - Leukocytes FunctionsHematology and Immunology - Leukocytes Functions
Hematology and Immunology - Leukocytes FunctionsMedicoseAcademics
 

Último (20)

Glomerular Filtration and determinants of glomerular filtration .pptx
Glomerular Filtration and  determinants of glomerular filtration .pptxGlomerular Filtration and  determinants of glomerular filtration .pptx
Glomerular Filtration and determinants of glomerular filtration .pptx
 
Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)
 
Measurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptxMeasurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptx
 
Book Call Girls in Yelahanka - For 7001305949 Cheap & Best with original Photos
Book Call Girls in Yelahanka - For 7001305949 Cheap & Best with original PhotosBook Call Girls in Yelahanka - For 7001305949 Cheap & Best with original Photos
Book Call Girls in Yelahanka - For 7001305949 Cheap & Best with original Photos
 
call girls in paharganj DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in paharganj DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️call girls in paharganj DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in paharganj DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
 
Housewife Call Girls Bangalore - Call 7001305949 Rs-3500 with A/C Room Cash o...
Housewife Call Girls Bangalore - Call 7001305949 Rs-3500 with A/C Room Cash o...Housewife Call Girls Bangalore - Call 7001305949 Rs-3500 with A/C Room Cash o...
Housewife Call Girls Bangalore - Call 7001305949 Rs-3500 with A/C Room Cash o...
 
Low Rate Call Girls Mumbai Suman 9910780858 Independent Escort Service Mumbai
Low Rate Call Girls Mumbai Suman 9910780858 Independent Escort Service MumbaiLow Rate Call Girls Mumbai Suman 9910780858 Independent Escort Service Mumbai
Low Rate Call Girls Mumbai Suman 9910780858 Independent Escort Service Mumbai
 
Call Girl Koramangala | 7001305949 At Low Cost Cash Payment Booking
Call Girl Koramangala | 7001305949 At Low Cost Cash Payment BookingCall Girl Koramangala | 7001305949 At Low Cost Cash Payment Booking
Call Girl Koramangala | 7001305949 At Low Cost Cash Payment Booking
 
Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.
 
Housewife Call Girls Hsr Layout - Call 7001305949 Rs-3500 with A/C Room Cash ...
Housewife Call Girls Hsr Layout - Call 7001305949 Rs-3500 with A/C Room Cash ...Housewife Call Girls Hsr Layout - Call 7001305949 Rs-3500 with A/C Room Cash ...
Housewife Call Girls Hsr Layout - Call 7001305949 Rs-3500 with A/C Room Cash ...
 
Noida Sector 135 Call Girls ( 9873940964 ) Book Hot And Sexy Girls In A Few C...
Noida Sector 135 Call Girls ( 9873940964 ) Book Hot And Sexy Girls In A Few C...Noida Sector 135 Call Girls ( 9873940964 ) Book Hot And Sexy Girls In A Few C...
Noida Sector 135 Call Girls ( 9873940964 ) Book Hot And Sexy Girls In A Few C...
 
epilepsy and status epilepticus for undergraduate.pptx
epilepsy and status epilepticus  for undergraduate.pptxepilepsy and status epilepticus  for undergraduate.pptx
epilepsy and status epilepticus for undergraduate.pptx
 
Call Girls Jp Nagar Just Call 7001305949 Top Class Call Girl Service Available
Call Girls Jp Nagar Just Call 7001305949 Top Class Call Girl Service AvailableCall Girls Jp Nagar Just Call 7001305949 Top Class Call Girl Service Available
Call Girls Jp Nagar Just Call 7001305949 Top Class Call Girl Service Available
 
Case Report Peripartum Cardiomyopathy.pptx
Case Report Peripartum Cardiomyopathy.pptxCase Report Peripartum Cardiomyopathy.pptx
Case Report Peripartum Cardiomyopathy.pptx
 
Call Girls Service Nandiambakkam | 7001305949 At Low Cost Cash Payment Booking
Call Girls Service Nandiambakkam | 7001305949 At Low Cost Cash Payment BookingCall Girls Service Nandiambakkam | 7001305949 At Low Cost Cash Payment Booking
Call Girls Service Nandiambakkam | 7001305949 At Low Cost Cash Payment Booking
 
Epilepsy
EpilepsyEpilepsy
Epilepsy
 
Call Girls Service in Virugambakkam - 7001305949 | 24x7 Service Available Nea...
Call Girls Service in Virugambakkam - 7001305949 | 24x7 Service Available Nea...Call Girls Service in Virugambakkam - 7001305949 | 24x7 Service Available Nea...
Call Girls Service in Virugambakkam - 7001305949 | 24x7 Service Available Nea...
 
Report Back from SGO: What’s New in Uterine Cancer?.pptx
Report Back from SGO: What’s New in Uterine Cancer?.pptxReport Back from SGO: What’s New in Uterine Cancer?.pptx
Report Back from SGO: What’s New in Uterine Cancer?.pptx
 
Radiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxRadiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptx
 
Hematology and Immunology - Leukocytes Functions
Hematology and Immunology - Leukocytes FunctionsHematology and Immunology - Leukocytes Functions
Hematology and Immunology - Leukocytes Functions
 

Treatment outcome case studies perez

  • 1. Case Studies in the Management of HIV-Positive Patients Stephen Perez, RN, NP, AAHIV-S
  • 2. Overview and Objectives • Review case studies involving the management of HIV-infected patient • Apply knowledge to determine appropriate ARV initiation and management for case patients • Engage in group discussion around the complexities of initiating ARV’s 2
  • 3. Case One: Juan • 25 y.o. Salvadorian, bisexual male. • Tested HIV-positive 4 weeks ago after visiting a county clinic and being treated for GC/CT • He is presenting for his first visit with you today • Prior to his visit to the county clinic, he has not had care since 1 year ago, he has not had primary care since childhood
  • 4. Case One: Juan • Juan brings a copy of his records from the county clinic – RX with Rocephin and Azithromycin – Twinrix #1 – Positive HIV WB – Positive GC NAAT (urine), RPR non- reactive, neg CT NAAT (urine). – Information flyer for your clinic 4
  • 5. Case One: Juan • On initial history: – UTI symptoms 6 weeks ago, now resolved – No other recent illnesses – No history of chronic illness – Family history relatively unknown • Married with one child in El Salvador – No Surgical Hx – ED visit 1 year ago for CAP, resolved with abx, prior ED visit 3 years ago, for laceration at work – NKDA, no current meds 5
  • 6. Case One: Juan • What else do we want to know about Juan? 6
  • 7. Case One: Juan • What other information do we want to know about Juan? • Previous testing – No previous HIV tests or STD history, no hx of ARV’s • ETOH, Illicit Drugs – Drinks alcohol 3-4 times a week, intoxicated 2 times a week (approx. 8 beers) • Sexual Activity – Sexually active with 2 male partners last sexual activity last week. Oral sex (no condoms), receptive anal sex (with condoms) • Work History – Works as a cook at a local 24 hour restaurant. He works alternate day and night shifts • Immunizations – Unknown, received a “shot” at the ED 3 years ago after sutures • Mental Health History 7 – None reported
  • 8. Case One: Juan • Physical Exam – WNWD, NAD, BMI 26, VS wnl – Mild palpable LN in anterior cervical chain – 4cm well healed scar on left palm – Otherwise unremarkable 8
  • 9. Case One: Juan • What Lab Tests Do We Want to Order? – CD4 count – Viral Load – CMP/CBC – Hepatitis Serologies (HAV, HBV, HCV) – Urinalysis – Genotype – Fasting Plasma Glucose, Fasting Lipids – Repeat Urine GC/CT, Throat GC/CT – PPD – Anti-Toxoplasma IgG 9
  • 10. Case One: Juan • Results – CBC/CMP within normal – CD4 644, VL is 56,346 – HBsAg neg, anti HBc Ab positive, anti HBs Ab positive, Total anti-HAV Ab postive, anti HCV Ab neg. – UA wnl – Genotype is pan-sensitive – Lipids: TC-1, LDL-130, HDL-50, TG-200. – FPG: 98 – Repeat GC/CT negative – PPD 0mm, anti-toxo is <6.5 10
  • 11. Case One: Juan Should Juan Start Antiretroviral Therapy (Audience Response)? 1. Yes 2. No 3. Maybe So 11
  • 12. Case One: Juan • What ARV’s Would You Recommend for Juan? – ARV Naïve – Genotype is pan-sensitive – Works odd hours 12
  • 13. Case One: Juan What ARV’s Would You Recommend for Juan? (Audience Response) 1. Atripla (EFV/TDF/FTC) 2. Prezista, Norvir and Truvada (DAR/r + TDF/FTC) 3. Reyataz, Norvir and Truvada (ATV/r +TDF/FTC) 4. Isentress and Truvada (RAL + TDF/FTC) 5. Complera 13 (RPV/FTC/TDF)
  • 14. Case One: Juan • What are benefits and risks of your selected ARV regimen? • If starting Juan at his next visit, when do you want him to return for follow-up? • How would you monitor his response to therapy? 14
  • 16. Case Two: Janice • 34 year-old A.A. female with HIV infection • She was diagnosed 4 years ago when she presented to an OB clinic at 26 weeks, but has not been engaged in care since her delivery. • She recently moved to the area, and is concerned because she has been feeling tired. Also has some intermittent throat pain 16
  • 17. Case Two: Janice • She does not have her previous records with her but tells you the following – She took HIV meds during pregnancy but can’t remember the names – Remembers “a lot of pills” (yellow and white ) – Her daughter is HIV negative – She stopped her meds after delivering 17
  • 18. Case Two: Janice • On initial history: – Has been feeling tired for about 3 months – Intermittent night sweats, intermittent pain with swallowing ROS otherwise negative – Family history • Mother A&W with HTN, DM2, Father Deceased from MI • One daughter, 3 yrs old – Surgical Hx includes C-Section 3 yrs ago – ED visit 6 months ago for GI symptoms – Allergic to Sulfa – GYN: G2 P1, SAB X1, irregular menses, LMP 2 months ago 18
  • 19. Case Two: Janice • What other information do we want to know about Janice? • HIV History – Viral Load was undetectable while on meds, thinks her CD4 count was around 200, had a lot of GI side effects with the meds, but never missed any doses. • ETOH, Illicit Drugs – Denies any alcohol or drug use. Does not smoke • Sexual Activity – Has a monogamous male partner, who is HIV negative. They use condoms 100% of the time. • Work History – Full time work at small PR firm, does not have insurance because she doesn’t want anyone at work to know about her HIV. • Immunizations – Unknown, had a PPD from OB which was negative • Mental Health History – Was treated for depression 5 years ago after her father passed away (x 1 year) 19
  • 20. Case Two: Janice • Physical Exam – WNWD, NAD, BMI 24, VS: BP 144/90 otherwise wnl – Well healed surgical scar from C-section – White coating noted on posterior oropharynx, scrapable with tongue depressor – Otherwise unremarkable 20
  • 21. Case Two: Janice • What Lab Tests Do We Want to Order? – CD4 count – Viral Load – CMP/CBC – Hepatitis Serologies (HAV, HBV, HCV) – Urinalysis – Genotype – Fasting Plasma Glucose, Fasting Lipids – RPR, GC/CT – PPD – Pregnancy Test – Anti-Toxoplasma IgG 21
  • 22. Case Two: Janice • Results – CBC Hgb: 8.7, Hct: 30, Plt 75,000, CMP: WNL – CD4 75, VL is 132,675 – HBV sAg neg, anti HBc Ab negative, anti HBVs Ab positive, HAV total Ab postive, anti HCV Ab neg. – Genotype is pan-sensitive – Lipids: TC-175, LDL-98, HDL-40, TG-130. FPG: 98 – Urine Pregnancy test, negative, UA wnl – PPD 0mm – G6PD <3 U/g Hb – Anti-toxoplasma IgG <6.5 IU/ml 22
  • 23. Case Two: Janice Does Janice needs PCP prophylaxis (Audience Response)? 1. Yes 2. No 3. Maybe So 23
  • 24. Case Two: Janice What is the best option for PCP Prophylaxis for Janice (Audience Response)? 1. Dapsone 100mg 1 tablet daily 1. Bactrim DS 1 tablet daily 1. Bactrim DS 1 tablet Q MWF 1. Mepron 1500 mg PO daily 1. Crossing your fingers 24
  • 25. Case Two: Janice Should Janice Start Antiretroviral Therapy (Audience Response)? 1. Yes 2. No 3. Maybe So 25
  • 26. Case Two: Janice • What ARV’s Would You Recommend for Janice? – Her genotype is pan- sensitive – You show her a medication chart in your office and she identifies Combivir and Kaletra as her previous regimen 26
  • 27. Case Two: Janice What ARV’s Would You Recommend for Janice? (Audience Response) 1. Atripla (EFV/TDF/FTC) 2. Prezista, Norvir and Truvada (DAR/r + TDF/FTC) 3. Reyataz, Norvir and Truvada (ATV/r +TDF/FTC) 4. Isentress and Truvada (RAL + TDF/FTC) 27
  • 28. Case Two: Janice • What are benefits and risks of your selected ARV regimen? • If starting Janice at her next visit, when do you want her to return for follow-up? • How would you monitor her response to therapy? 28
  • 30. Case Three: Donna • 53 year-old Caucasian female with HIV infection • She was diagnosed 2 years ago while incarcerated. • She was recently released from prison and has not been treated for HIV in the past. She is presenting today for primary care/HIV Care 30
  • 31. Case Three: Donna • She has brought in her previous records from prison – CD4 count has been between 600 and 800 with a nadir of 575 cells/mm3 – Viral Loads ~ 3,000 copies – HBV sAg neg, anti HBc Ab negative, anti HBVs Ab positive, HAV total Ab postive, anti HCV Ab neg. – Genotype is pan-sensitive – She also has hypertension and hypothyroid disease for which she is taking: • HCTZ 25 mg • Lisinopril 20 mg • Levothyroxine 100 mcg – She has been taking prescriptions as above 31
  • 32. Case Three: Donna • On initial history: – Has been feeling well in the past few months – Is concerned about finding work and getting in touch with family – Family history • Mother deceased from trauma, Father Deceased from MI, Sister alive 49 with hypothyroid disease and high cholesterol • Two adult children whom she has little contact with, Alive and Well as far as she knows – Surgical Hx unremarkable – NKDA – GYN: G2 P2, LMP 5 years ago 32
  • 33. Case Three: Donna • What other information do we want to know about Donna? • HIV History – Previous HIV test 10 years ago which was negative. Risk factor is heterosexual contact • ETOH, Illicit Drugs – Drinking 3-4 beers a day, no illicit drugs. Smokes ½ pack a day • Sexual Activity – Has a monogamous female partner, who is HIV negative. They use barrier protection 50% of the time • Work History – Previous work in retail. Is currently applying for jobs in the area • Immunizations – UTD, had a PPD 9 mos ago which was negative • Mental Health History – Was treated for depression but has been off meds since she was released 33
  • 34. Case Three: Donna • Physical Exam – WNWD, NAD, BMI 28, VS: BP 128/84 otherwise wnl – Unremarkable PE 34
  • 35. Case Three: Donna • What Lab Tests Do We Want to Order? – CD4 count – Viral Load – CMP/CBC – Urinalysis – Fasting Plasma Glucose, Fasting Lipids – RPR, GC/CT, PAP – Anti-Toxoplasma IgG 35
  • 36. Case Three: Donna • Results – CBC/CMP: WNL – CD4: 672, CD4 %: 28 – Viral Load: 3,234 copies – Lipids: TC-250, LDL-162, HDL-36, TG-224. FPG: 110 – UA wnl – PAP negative – GC/CT, RPR negative – G6PD <3 U/g Hb – Anti-toxoplasma IgG <6.5 IU/ml 36
  • 37. Case Three: Donna Should Donna Start Antiretroviral Therapy? (Audience Response) 1. Yes 2. No 3. Maybe So 37
  • 38. Case Three: Donna • What ARV’s Would You Recommend for Donna? – Her genotype is pan-sensitive – She is ARV Naïve 38
  • 39. Case Three: Donna What ARV’s Would You Recommend for Donna? (Audience Response) 1. Atripla (EFV/TDF/FTC) 2. Prezista, Norvir and Truvada (DAR/r + TDF/FTC) 3. Reyataz, Norvir and Truvada (ATV/r +TDF/FTC) 4. Isentress and Truvada (RAL + TDF/FTC) 5. Complera (RPV/FTC/TDF) 39
  • 40. Case Three: Donna • What are benefits and risks of your selected ARV regimen? • If starting Donna at her next visit, when do you want her to return for follow-up? • How would you monitor her response to therapy? 40
  • 41. Case Three: Donna QUESTIONS? 41
  • 42. AETC NCHCMC Contacts Clinical Team Contacts Stephen Perez, RN, NP, AAHIVS, HIV Clinical Specialist stephen@healthhiv.org Mona Moore, PA-C, MA, AAHIVS, HIV Clinical Program Specialist Kmona@healthhiv.org 42
  • 43. HealthHIV AETC NCHCMC 2000 S Street NW Washington, DC 20009 www.NCHCMC.org 202-232-6749

Notas do Editor

  1. What about an HLA-B5701 what about a co-recptor tropism assay?
  2. What is Janice’s STAGE ACCORDING TO CDC STAGING. B3, she techincally does not have any AIDS indicator conditions, oropharyngeal thrush is not an aids indicator, but esophageal is. Does she need any opportunistic prophylaxis? Yes, for what? Should we take into account the G6PD finding? Can she be on Mepron?
  3. rop